Mural Health Technologies, a next-generation clinical trial participant management platform, today announced that it has raised $8 million in seed funding, led by Bessemer Venture Partners, with participation from Virtue VC, Operator Partners, Arkitekt Ventures, Correlation Ventures, and Project Mayhem Ventures.

Mural Health is a next-generation participant management platform. The Company's Mural Link technology platform is designed to make it easier to participate in clinical trials, thereby improving clinical study operations and the quality of clinical data sets. The Mural Link platform improves participant retention and engagement, increases protocol compliance, and increases enrollment rates.